These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25354010)

  • 1. [Medical appetite stimulation for patients with advanced cancer].
    Enevoldsen K; Jarlbæk L; Herrstedt J
    Ugeskr Laeger; 2014 Oct; 176(44):. PubMed ID: 25354010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of the treatment of cancer-associated anorexia and weight loss.
    Yavuzsen T; Davis MP; Walsh D; LeGrand S; Lagman R
    J Clin Oncol; 2005 Nov; 23(33):8500-11. PubMed ID: 16293879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC)].
    Desport JC; Blanc-Vincent MP; Gory-Delabaere G; Bachmann P; Béal J; Benamouzig R; Colomb V; Kere D; Melchior JC; Nitenberg G; Raynard B; Scheiner S; Senesse P
    Bull Cancer; 2000 Apr; 87(4):315-28. PubMed ID: 10827350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological options for advanced cancer patients with loss of appetite and weight.
    Behl D; Jatoi A
    Expert Opin Pharmacother; 2007 Jun; 8(8):1085-90. PubMed ID: 17516872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of cachexia: any progress?
    Bruera E
    Support Care Cancer; 1998 Mar; 6(2):109-13. PubMed ID: 9540168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hunger for hunger: a review of palliative therapies for cancer-associated anorexia.
    Childs DS; Jatoi A
    Ann Palliat Med; 2019 Jan; 8(1):50-58. PubMed ID: 29860861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of pharmacological cachexia interventions: systematic review and network meta-analysis.
    Saeteaw M; Sanguanboonyaphong P; Yoodee J; Craft K; Sawangjit R; Ngamphaiboon N; Shantavasinkul PC; Subongkot S; Chaiyakunapruk N
    BMJ Support Palliat Care; 2021 Mar; 11(1):75-85. PubMed ID: 33246937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New strategies for tumor-related cachexia].
    HNO; 1997 Nov; 45(11 Suppl):1-8. PubMed ID: 9509016
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.
    Maltoni M; Nanni O; Scarpi E; Rossi D; Serra P; Amadori D
    Ann Oncol; 2001 Mar; 12(3):289-300. PubMed ID: 11332139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological therapy of cancer anorexia-cachexia].
    Cardona D
    Nutr Hosp; 2006 May; 21 Suppl 3():17-26. PubMed ID: 16768027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorexia/cachexia in patients with HIV: lessons for the oncologist.
    Von Roenn JH; Knopf K
    Oncology (Williston Park); 1996 Jul; 10(7):1049-56; discussion 1062-4, 1067-8. PubMed ID: 8837121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
    Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
    Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appetite stimulants: the unsolved truth.
    Baron M
    Health Care Food Nutr Focus; 2000 Jun; 16(10):5-7. PubMed ID: 11182996
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacological treatment of cachexia.
    Argilés JM; Almendro V; Busquets S; López-Soriano FJ
    Curr Drug Targets; 2004 Apr; 5(3):265-77. PubMed ID: 15058312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
    Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
    Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standards, Options and Recommendations for the use of appetite stimulants in oncology (2000).
    Desport JC; Gory-Delabaere G; Blanc-Vincent MP; Bachmann P; Béal J; Benamouzig R; Colomb V; Kere D; Melchior JC; Nitenberg G; Raynard B; Schneider S; Senesse P;
    Br J Cancer; 2003 Aug; 89 Suppl 1(Suppl 1):S98-S100. PubMed ID: 12915909
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging drugs for cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Expert Opin Emerg Drugs; 2007 Nov; 12(4):555-70. PubMed ID: 17979599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appetite and appetite stimulants.
    Shaw C
    Eur J Cancer Care (Engl); 1993; 2(3):121-4. PubMed ID: 10889628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.